Paul Conley
InvestorChairman & CEO at GENERAL INCEPTION · Managing Director at Paladin Capital Group · Venture Partner at Vertical Venture Partners · Venture Partner at OMX Ventures · fmr Board Member (NASDAQ: TXG) at 10x Genomics · +4 more
Palo Alto, California, United States
Find your path to Paul
489 people in our graph share verified history with Paul — schools, employers, funds. One of them is your warm intro.
About
Paul Conley is CEO and co-founder of General Inception, an organization focused on company formation for deep-tech and life-science startups. General Inception operates as an institutional co-founder to technical founders and invests capital from its own balance sheet rather than functioning as a venture capital firm.
Contact· self-published, not guessed
Likely email· guessed from name + firm domain, not firm-published
- p•••@generalinception.comreveal75% confident
Invests in
AI & Machine LearningBiotechCybersecurityDeep TechDefense TechEnterprise SoftwareHardwareHealthtechPropTechSaaSSemiconductors
Board director at Partillion
Intro paths
In turn, Paul can intro founders to Partillion's investors below.
Partillion's investors · 4
Co-founders at Partillion


Director at 1859
Intro paths
In turn, Paul can intro founders to 1859's investors below.
Board director at Switchback Systems
Intro paths
In turn, Paul can intro founders to Switchback Systems's investors below.
Experience
- General InceptionCEO & Co-foundercurrent2020 — presentPalo Alto, California, United States
- Vertical Venture PartnersVenture Partnercurrent2015 — presentPalo Alto, CA
- Paladin Capital GroupManaging Director for Venture Studio Operationscurrent2007 — presentWashington DC-Baltimore Area
- Constructive BioBoard Membercurrent2022 — presentCambridge, England, United Kingdom
- 10X Genomicsfmr Board Member (NASDAQ: TXG)current2012 — presentSan Francisco Bay Area
- Twist Biosciencefmr Board Member (NASDAQ: TWST)current2013 — presentSan Francisco Bay Area
- Aralez BioBoard Observercurrent2024 — present
- Partillion BioscienceBoard Membercurrent2023 — present
- Attune Neurosciences, Inc.Board Membercurrent2022 — present
- Alida BiosciencesBoard Membercurrent2021 — present
- Tactile Therapeutics, Inc.Board Membercurrent2022 — present
- Menlo MicroBoard Membercurrent2015 — presentIrvine, CA
- VoiceCare AIStrategic Advisorcurrent2024 — present
- Delix TherapeuticsInvestor (co-founder)current2018 — present
- Inscripta, Inc.Board Observercurrent2017 — presentBoulder, CO
- COMPASS Pathways plcInvestor (NASDAQ: CMPS)current2020 — present
- Ginkgo Bioworks, Inc.Investor (NYSE: DNA)current2013 — presentCambridge, MA
- Mythic Therapeutics, Inc.Investorcurrent2020 — present
- Tasso, Inc.Board Observercurrent2018 — presentGreater Seattle Area
- Edifice Health, Inc.Board Membercurrent2020 — present
- SyntheX, Inc.Investorcurrent2017 — present
- Hexagon BioInvestorcurrent2017 — presentMenlo Park, California, United States
- Cellsonics Inc.Board Membercurrent2017 — presentSunnyvale, California, United States
- Isolation Bio Inc.Board Membercurrent2016 — presentSan Francisco, CA
- NanoCellect Biomedical, Inc.Board Membercurrent2017 — presentSan Diego, CA
- AnomaliBoard Observercurrent2014 — presentRedwood City, CA
- IntabioBoard Observer (SOLD to Danaher/SciEx)2017 — 2020San Francisco Bay Area
- VerodinInvestor (NASDAQ: FEYE)2015 — 2019Reston, VA
- ProtectWise, Inc.Board Observer (Exit to Verizon)2014 — 2018Denver Metropolitan Area
- NewlansBoard Member (SOLDto TDK/Epcos)2010 — 2015Acton, MA
- WispryBoard Member (SOLD to AAC Technologies)2008 — 2015Irvine, CA
- Arxan TechnologiesBoard Member (SOLD to TA Associates)2007 — 2013Rockville, MD
- Luminus DevicesBoard Member (SOLD to Sanan Opto)2008 — 2013Sunnyvale, CA
- NexidiaBoard Observer (SOLD to NICE Systems)2007 — 2012
- QuantaLife, Inc. - A Bio-Rad CompanyBoard Member (SOLD to BioRad)2008 — 2011
- Modal LogicManaging Partner2006 — 2007
- BrightScaleCEO (Co-founder)2003 — 2006Los Gatos, CA
- Appfluent TechnologyChairman & CEO (co-founder)2000 — 2003
- Los Alamos National LaboratoryPost-doctoral Research1996 — 2000
Skills & more
+12 more
Private EquityProduct MarketingCorporate DevelopmentTeam BuildingMarketing StrategyCleantechManagement ConsultingRecruitingFinancial ModelingBiotechnologyEmerging MarketsSemiconductorsFrom Paul's professional profile.
Investments
Investor
Alida BioAmitreeAralez BioArxan TechnologiesConstructive BioEdifice HealthFixmoHealthTellInfinimmuneInscriptaLuminus DevicesMenlo MicroNanoCellect BiomedicalNewlansONITwist BioscienceWispry
Per curated public sources.
Colleagues at GENERAL INCEPTION
Frequently asked questions
- Who is Paul Conley?
- Paul Conley is CEO and co-founder of General Inception, an organization focused on company formation for deep-tech and life-science startups. General Inception operates as an institutional co-founder to technical founders and invests capital from its own balance sheet rather than functioning as a venture capital firm.
- Where does Paul Conley work?
- Paul Conley is Chairman & CEO at GENERAL INCEPTION and Board director at Partillion and Board director at Switchback Systems.
- What does Paul Conley invest in?
- Paul Conley invests in AI & Machine Learning, Biotech, Cybersecurity, Deep Tech, Defense Tech, Enterprise Software, Hardware, Healthtech, PropTech, SaaS, Semiconductors.
- What companies has Paul Conley invested in?
- Investments tracked here include Alida Bio, Amitree, Aralez Bio, Arxan Technologies, Constructive Bio, Edifice Health, Fixmo, HealthTell, Infinimmune, Inscripta, Luminus Devices, Menlo Micro, and 5 more.
- Where did Paul Conley go to school?
- Paul Conley studied at UC San Diego (PhD, AMES (Computational Physics)); UC San Diego (ME, Bioengineering); University of Virginia (MS/BS, Mechanical & Aerospace Engineering).
Same school
Also attended UC San Diego577
+ 571 more
Also attended University of Virginia802
+ 796 more
Shared employers
Also worked at Menlo Micro10
+ 4 more































































